Catalyst Wire Dossier Catalyst Wire Dossier

TISSUEBLUE

Brilliant Blue G · D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TISSUEBLUE, covering 2019-12-20 to 2025-04-04. Get the full timeline:

Most recent: FDA Approved: TISSUEBLUE — Supplemental Application (D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.)

See pricing